ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Zyus Life Sciences Corporation

Zyus Life Sciences Corporation (ZYUS)

0.83
-0.02
(-2.35%)
Cerrado 22 Diciembre 3:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.83
Postura de Compra
0.80
Postura de Venta
0.88
Volume Operado de la Acción
1,336
0.83 Rango del Día 0.83
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.85
Precio de Apertura
0.83
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
70,847,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.38
Beneficio por acción (BPA)
-0.6
turnover
351k
Beneficio neto
-42.59M

Acerca de Zyus Life Sciences Corporation

Sector
Pharmaceutical Preparations
Industria
Oil And Gas Field Expl Svcs
Sitio web
Sede
Toronto, Ontario, Can
Fundado
2023
Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ZYUS. The last closing price for Zyus Life Sciences was $0.85. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0.00 to $ 0.00.

Zyus Life Sciences currently has 70,847,000 shares in issue. The market capitalisation of Zyus Life Sciences is $60.22 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.38.

ZYUS Últimas noticias

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ZYUS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Zyus Life Sciences?
El precio actual de las acciones de Zyus Life Sciences es $ 0.83
¿Cuántas acciones de Zyus Life Sciences están en circulación?
Zyus Life Sciences tiene 70,847,000 acciones en circulación
¿Cuál es la capitalización de mercado de Zyus Life Sciences?
La capitalización de mercado de Zyus Life Sciences es CAD 60.22M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Zyus Life Sciences?
Zyus Life Sciences ha negociado en un rango de $ 0.00 a $ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Zyus Life Sciences?
El ratio precio/beneficio de Zyus Life Sciences es -1.38
¿Cuál es el ratio de efectivo a ventas de Zyus Life Sciences?
El ratio de efectivo a ventas de Zyus Life Sciences es 166
¿Cuál es la moneda de reporte de Zyus Life Sciences?
Zyus Life Sciences presenta sus resultados financieros en CAD
¿Cuál es el último ingresos anual de Zyus Life Sciences?
El último ingresos anual de Zyus Life Sciences es CAD 351k
¿Cuál es el último beneficio anual de Zyus Life Sciences?
El último beneficio anual de Zyus Life Sciences es CAD -42.59M
¿Cuál es la dirección registrada de Zyus Life Sciences?
La dirección registrada de Zyus Life Sciences es 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3
¿Cuál es la dirección del sitio web de Zyus Life Sciences?
La dirección del sitio web de Zyus Life Sciences es www.zyus.com
¿En qué sector industrial opera Zyus Life Sciences?
Zyus Life Sciences opera en el sector OIL AND GAS FIELD EXPL SVCS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
GNFIGenifi Inc
$ 0.015
(200.00%)
4k
GHR.HGolden Harp Resources Inc
$ 0.10
(185.71%)
2.73k
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
2k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
1.1k
GAR.HGreen Arrow Resources Inc
$ 0.045
(80.00%)
1,000
CBAChampion Bear Resources Ltd
$ 0.015
(-62.50%)
101k
NIKL.HGK Resources LTD
$ 0.045
(-50.00%)
1,000
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
106.09k
COOOstrom Climate Solutions Inc
$ 0.05
(-50.00%)
109.5k
QNCQuantum Emotion Corp
$ 0.435
(26.09%)
7.32M
GXUGoviEx Uranium Inc
$ 0.055
(10.00%)
4.68M
FUUF3 Uranium Corp
$ 0.25
(6.38%)
3.64M
AUUAALUULA Composites Inc
$ 0.05
(0.00%)
3.63M
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M
jtaylor042 jtaylor042 20 minutos hace
Well you're one who knows where the lifeboat is and...yet I still find you here.
NWBO
vuletini vuletini 22 minutos hace
Built it and they will come....
SHIBUSD
jeunke22 jeunke22 26 minutos hace
I have seen your recommendations across a number of boards. I am very aware of the risk involved when investing in start ups. Thanks for reminding me. I wil put you back where you belong! Bye bye!
LWLG
SteveSchiets SteveSchiets 33 minutos hace
Yp, I know what to post to get your blood going. That's just a bit funny. I won't do it again. Of course you can post whatever you want.
This board is not swamped by newcomers, so I guess you don't have a lot of work. We are all adults here, no daily warnings is needed, imo.
I hold 7
SEV
biosectinvestor biosectinvestor 35 minutos hace
Obviously not my point. You say stuff like this, yet either you never sell or you never really owned. Making noisy exits before they sell, for years, makes very little sense for real owners. Shorts and swing traders are frequently “exiting”,swing traders claim to do so, before news. And then want
NWBO
jeunke22 jeunke22 1 hora hace
Hope you understand that the $ 120 includes the PIC part in the transceiver market as well.
Conclusion: comparison with UDC between 40 and 120.
I will be happy with $ 40+ !
LWLG
LoveThemStocks LoveThemStocks 1 hora hace
I was told the same that you were told about falling in love with any subpenny and penny stock, but the reason for that is that many of the subpenny and penny stocks are scam companies. I'm in two companies right now that aren't scam stocks and both of them happens to be Tonix and Amprius. Tonix is
TNXP
TurboMountain96 TurboMountain96 1 hora hace
Osisko went for 4.90 a share, we are trading at 0.12 currently, say we sold at 1.50 a share worst ways I think we would love a 12x 😀
FFMGF
SilkRoad SilkRoad 1 hora hace
The difference is it is happening NOW.
KBLB
SilkRoad SilkRoad 1 hora hace
Your childish and antiquated arguments no longer match the current state of affairs. KBLB is well on its way to metric tonnage. 2025 will blow your mind. So get ready for it.
KBLB
happyglass happyglass 1 hora hace
When did he say that? All I have heard from him is that he is spreading cannabis across the planet and getting position in the US so he can pivot as soon as it is legal for him to do so. That is why I buy this stock. He is sensible and agile and thinks on his feet. Nobody thought it would take thi
TLRY
jeunke22 jeunke22 1 hora hace
Need to replace “modulator only” market with transceiver market to make the ratio comparison to Universal Display ( with the total display market) correct . Otherwise I would have wrongly assumed that Lightwave would have 100% of the optical modulator market, which is incorrect of course. The opt
LWLG
Sheepdog Sheepdog 1 hora hace
Q1 has been filed. Another 600K loss making it over $21M of accumulated losses for Roger. That's $21M that shareholders have given the company and has been lost by Roger in his 10 years of keeping anybody from running the company.
FUNN
knrorrel knrorrel 1 hora hace
https://www.stockscores.com/charts/charts/?ticker=qnccf
QNCCF
ElectricMountain53 ElectricMountain53 1 hora hace
The OLED comparison again. Just stop the assumptions and possible price predictions, it´s pathetic. Let´s wait for the long-awaited deals! And it better happens ASAP!
LWLG
knrorrel knrorrel 1 hora hace
https://www.stockscores.com/charts/charts/?ticker=qnccf
knrorrel knrorrel 2 horas hace
my favorites in the Christmas week are $NVNI $QNCCF $GVSI $FORW ( ..... and für 2025 )

$NVNI - when the move up comes, it always looks like real money is flowing in, when $NVNI was going through $10 and $11 like butter, there was strong buying - like with NUKK before they had to go f
FORW GVSI NUKK
knrorrel knrorrel 2 horas hace
my favorites in the Christmas week are $NVNI $QNCCF $GVSI $FORW ( ..... and für 2025 )

$NVNI - when the move up comes, it always looks like real money is flowing in, when $NVNI was going through $10 and $11 like butter, there was strong buying - like with NUKK before they had to go f
FORW GVSI NUKK
CanItBThisEZ2Make CanItBThisEZ2Make 2 horas hace
BEST SELLERS RANK (BSR) IS 894 69 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
gimmee greenbacks gimmee greenbacks 2 horas hace
The Definition of a stock board Troll.

Cries like a five year old if a mention is made on that POS bag he’s holding is visited.

How ruch.

What’s good for the goose is good for the gander..



BIEL
BIEL
Not likely Not likely 2 horas hace
I'm addictive with you folk.


Sometimes the lost need to be found.
SPZI
coccyx coccyx 2 horas hace
Wow, the desperation is astounding.

Kool Aid Man and I-Glow, you’re both throwing out BS takes without understanding how Bloxcross operates or how SPZI reports its numbers. I'm sure it was intentional.

First, Bloxcross generates revenue by facilitating global transactio
SPZI
sylvia07 sylvia07 2 horas hace
It's very telling, why they are here everyday for years, its not out of the goodness of their hearts!
DBMM
rx7171 rx7171 2 horas hace
This is not true.
The MAA if approved allows the drug to be marketed in all the EU countries.
That is the point of the “centralized procedure”.

Type in “definition of centralized procedure in EMA MAA”.

https://www.google.com/search?q=defintion+of+centrikiz
AVXL

Su Consulta Reciente

Delayed Upgrade Clock